Sequence and cognitive analyses of two virulence-associated markers of bluetongue virus serotype 17

Intervirology

Volumn 40, Issue 4, 1997, Pages 226-231

  Bernard, Kristen A ^a   Israel, Barbara A ^a   Wilson, William C ^b   Schultz, Kevin T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b USDA ARS   (United States)

Author keywords

Bluetongue virus; Sequence analyses; Virulence markers; Virulence subject index

Indexed keywords

ARTICLE; BLUETONGUE ORBIVIRUS; GENETIC VARIABILITY; GENOME; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VIRUS VIRULENCE;

BLUETONGUE VIRUS; RNA VIRUSES;

EID: 2642650364     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150551     Document Type: Article

References (41)

1. Bernard KA, Israel BA, Thompson LH, Homan EJ, Schultz KT: Virulence-associated antigenie and genetic characteristics of bluctonguc virus-17 isolates, Virology 1994:201:321-329.
2. Borden EC, Shope RE, Murphy FA: Physicochemical and morphological relationships of some arthropod-borne viruses to bluctongue virus - A new taxonomic group, J Gen Virol 1971:13:261-271.
3. Murphy FA, Borden EC, Shope RE, Harrison A: Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus - A new taxonomic group, Electron microscopic studies, J Gen Virol1971;13:273-288.
4. Verwoerd DW, Louw H, Oellermann RA: Characterization of bluetongue virus ribonucleic acid, J Virol 1970:5:1-7.
5. Grubman MJ, Appleton JA, Lctchworth GJ: Identification of bluctongue virus type 17 genome segments coding for polypeptides associated with virus neutralization and intergroup reactivity, Virology 1983;131:355-366.
6. Mertens PP, Brown F, Sangar DV: Assignment of the genome segments of bluctongue virus type I to the proteins which they encode, Virology 1984;135:207-217.
7. Martin SA, Zwecrink HJ: Isolation and characterization of two types of bluetongue virus particles, Virology 1972;50:495-506.
8. Vcrwoerd DW, Els HJ, De Villiers EM, Huis-mans H: Structure of the bluetongue virus cap-sid, J Virol 1972:10:783-794.
9. Huismans H, Erasmus BJ: Identification of the serotype-specific and group-specific antigens of bluetongue virus, Onderstepport J Vet Res 1981:48:51-58.
10. Ghiasi H, Purdy MA, Roy P: The complete sequence of bluetongue virus serotype 10 segment 3 and its predicted VP3 polypeptide compared with those of BTV serotype 17. Virus Res 1985:3:181-190.
11. Kahlon J, Sugiyama K, Roy P: Molecular basis of bluetongue virus neutralization, J Virol 1983;48:627-632.
12. Parsonson IM: Pathology and pathogenesis of bluetongue infections, CurrTop Microbiol Immunol 1990;162:119-141.
13. Leudke AJ, Jochim MM: Clinical and serologic responses in vaccinated sheep given challenge inoculation with isolates of bluctongue virus, Am J Vet Res 1968;29:841-851.
14. Ghalib HW, Cherrington JM, Osburn BI: Viro-logical, clinical and serological responses of sheep infected with tissue culture adapted blue-tonguc virus serotypes 10, 11, 13 and 17. Vet Microbiol 1985;10:179-188.
15. Barber TL, Jones RH: Bluetongue virus, serotype 2: Vector transmission and pathogenicity for sheep, Proc Annu Meet US Anini Health Assoc 1984:88:545-555.
16. Huismans H, Howell PG: Molecular hybridization studies on the relationships between different serotypes of bluetongue virus and on the difference between the virulent and attenuated strains of the same serotype, Onderstcpoort J Vet Res 1973:40:93-103.
17. Gould AR, Eaton BT: The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses, Virus Res 1990:17:161-172.
18. Waldvogel AS, Anderson GA, Phillips DL, Os-bum BI: Infection of bovine fetuses at 120 days' gestation with virulent and avirulcnt strains of bluetongue virus serotype 11. Comp Immunol Microbiol Infect Dis 1992;15:53-63.
19. Carr MA, de Mattos CC, de Mattos CA, Osburn BI: Growth of a neuroinvasive strain of bluctongue virus in suckling mice, Arch Virol 1995:140:915-925.
20. Carr MA, de Mallos CC, de Mattos CA, Osburn BI: Association of bluctonguc virus gene segment 5 with ncuroinvasivcncss, J Virol 1994;68:1255-1257.
21. Bernard KB, Israel BA, Schultz KT: A complex neutralization domain of bluetongue virus serotype 17 defines a virulence-associated marker, Viral Immunol 1996;9:97-106.
22. Hubschle OJ: Bluetongue virus hemagglutination and its inhibition by specific sera, Arch Virol 1980;64:133-140.
23. Ghiasi H, Fukusho A, Eshita Y, Roy P: Identification and characterization of conserved and variable regions in the neutralization VP2 gene of bluetongue virus, Virology 1987; 160:100-109.
24. Purdy M, Petre J, Rov P: Cloning of the bluetongue virus L3 gene, J Virol 1984:51:754-759.
25. Kowalik TF, Yang YY, Li JK: Molecular cloning and comparative sequence analyses of bluetongue virus SI segments by selective synthesis of specific full-length DNA copies of dsRNA genes, Virology 1990:177:820-823.
26. Finney M, Nisson PE, Rashtchian A: Current Protocols in Molecular Biology; in Ausubel FM, Brent R, Kingston RE, Moore DD, Seid-man JG, Smith JA, Struhl K (eds): Current Protocols, New' York, Wiley, 1994. pp 15.7.1-15.7.11.
27. Gould AR, Hyatt AD, Eaton BT: Morphogenesis of a bluetongue virus variant with an amino acid alteration at a neutralization site in the outer coat protein, VP2. Virology 1988:165: 23-32.
28. De Maula CD, Heidner HW, Rossito PV, Pierce CM, MacLachlan NJ: Neutralization determinants of United States bluetongue virus serotype ten, Virology 1993;195:292-296.
29. Jewell JE, Mccham JO: Identification of an amino acid on VP2 that affects neutralization of bluetongue virus serotype 10. Virus Res 1994;33:139-144.
30. Pierce CM, Rossitto PV, MacLachlan NJ: Ho-motypic and heterotypic neutralization determinants of bluetongue virus serotype 17. Virology 1995;209:263-267.
31. Hwang GY, Li JK: Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluctongue virus 13. Virology 1993;195:859-862.
32. Hwang GY, Xiang M, Li J K: Analyses and conservation of sequences among the cognate L3 segments of the five United States bluctonguc viruses, Virus Res 1994:32:381-389.
33. Sugiyama K, Bishop DH, Roy P: Analyses of the genomes of bluctonguc viruses recovered in the United Sates, I, Oligonucleotide fingerprint studies that indicate the existence of naturally occurring réassortant BTV isolates, Virology 1981:114:210-217.
34. Heidner HW, lezzi LG, Osburn BI, MacLachlan NJ: Genetic variation and evolutionary relationships amongst bluctongue viruses endemic in the United States, Virus Res 1991:21: 91-109.
35. Pritchard LI, Gould AR, Wilson WC, Thompson LH, Mertens PP, Wade Evans AM: Complete nucleotide sequence of RNA segment 3 of bluetongue virus serotype 2 (ona-A), Phylogenetic analyses reveal the probable origin and relationship with other orbiviruscs, Virus Res 1995:35:247-261.
36. de Matlos CA, de Mattos CC, Osburn BI, MacLachlan NJ: Heterogeneity of the L2 gene of field isolates of bluetongue virus serotype 17 from the San Joaquin Valley of California, Virus Res 1994:31:67-87.
37. Gould AR: The complete nucleotide sequence of bluctongue virus serotype 1 RNA 3 and a comparison with other geographic serotypes from Australia, South Africa and the United States of America and with other orbivirus isolates, Virus Res 1987;7:169-183.
38. McColl KA, Gould AR, Pritchard LI, Melville L, Beilis G: Phylogenetic characterisation of bluetongue viruses from naturally-infected insects, cattle and sheep in Australia, Aust Vet J 1994;71:102-105.
39. Evans DM, Dunn G, Minor PD, Schild GC, Canti AJ, Stanway G, Almond JW, Currey K, Maizel JVJ: Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 polio vaccine genome, Nature 1985;314:548-550.
40. La Monica N, Meriam C, Racanicllo VR: Mapping of sequences required for mouse neurovi-rulencc of poliovirus type 2 Lansing, J Virol 1986:57:515-525.
41. Lipton HL, Calenoff M, Bandyopadhyay P, Miller SD, Dal Canto MC, Geretv S, Jensen K: The 5' noncoding sequences from a less virulent Thciler’s virus dramatically attenuate GDVII neurovirulence, J Virol 1991:65:4370-4377.